As Dycom Industries (DY) Shares Declined, New England Research & Management Trimmed Position; Wynnefield Capital Has Trimmed Position in Bioscrip (BIOS) by $1.48 Million as Stock Value Declined

April 23, 2018 - By Adrian Erickson

BioScrip, Inc. (NASDAQ:BIOS) Logo

New England Research & Management Inc decreased its stake in Dycom Industries (DY) by 19.68% based on its latest 2017Q4 regulatory filing with the SEC. New England Research & Management Inc sold 2,934 shares as the company’s stock declined 9.19% with the market. The institutional investor held 11,975 shares of the basic industries company at the end of 2017Q4, valued at $1.33 million, down from 14,909 at the end of the previous reported quarter. New England Research & Management Inc who had been investing in Dycom Industries for a number of months, seems to be less bullish one the $3.26 billion market cap company. The stock decreased 2.07% or $2.21 during the last trading session, reaching $104.59. About 216,824 shares traded. Dycom Industries, Inc. (NYSE:DY) has risen 13.44% since April 23, 2017 and is uptrending. It has outperformed by 1.89% the S&P500.

Nelson Obus decreased its stake in Bioscrip Inc (BIOS) by 19.45% based on its latest 2017Q4 regulatory filing with the SEC. Wynnefield Capital Inc sold 739,075 shares as the company’s stock declined 10.25% with the market. The hedge fund run by Nelson Obus held 3.06M shares of the health care company at the end of 2017Q4, valued at $8.91 million, down from 3.80 million at the end of the previous reported quarter. Wynnefield Capital Inc who had been investing in Bioscrip Inc for a number of months, seems to be less bullish one the $344.78 million market cap company. The stock decreased 0.74% or $0.02 during the last trading session, reaching $2.7. About 218,689 shares traded. BioScrip, Inc. (NASDAQ:BIOS) has risen 42.70% since April 23, 2017 and is uptrending. It has outperformed by 31.15% the S&P500.

Since March 7, 2018, it had 0 insider purchases, and 1 sale for $284,044 activity.

Investors sentiment increased to 1.01 in Q4 2017. Its up 0.01, from 1 in 2017Q3. It is positive, as 34 investors sold DY shares while 109 reduced holdings. 55 funds opened positions while 89 raised stakes. 29.64 million shares or 4.71% less from 31.11 million shares in 2017Q3 were reported. Ftb Advsrs Inc stated it has 0% of its portfolio in Dycom Industries, Inc. (NYSE:DY). Mason Street Advsrs Ltd Liability Corporation reported 0.04% stake. Smith Graham Inv Advisors Ltd Partnership stated it has 0.74% of its portfolio in Dycom Industries, Inc. (NYSE:DY). Gabelli Funds Limited Company has invested 0.02% in Dycom Industries, Inc. (NYSE:DY). New England & Management Inc invested 0.95% in Dycom Industries, Inc. (NYSE:DY). Alpine Woods Llc holds 0.28% or 51,140 shares in its portfolio. Vident Advisory Ltd Liability accumulated 27,646 shares. Raymond James Svcs Advsrs, Florida-based fund reported 4,050 shares. Truenorth Inc owns 0.12% invested in Dycom Industries, Inc. (NYSE:DY) for 2,367 shares. State Street Corporation stated it has 0.01% of its portfolio in Dycom Industries, Inc. (NYSE:DY). Dorsey & Whitney Trust Limited Co reported 2,357 shares. Cubist Systematic Strategies Ltd Liability Corp holds 0.02% in Dycom Industries, Inc. (NYSE:DY) or 2,770 shares. Gemmer Asset Management Limited Co holds 146 shares or 0.01% of its portfolio. National Bank & Trust Of America Corp De has invested 0.01% in Dycom Industries, Inc. (NYSE:DY). The Pennsylvania-based Pnc Group has invested 0.03% in Dycom Industries, Inc. (NYSE:DY).

New England Research & Management Inc, which manages about $167.47M and $139.75M US Long portfolio, upped its stake in Terex (NYSE:TEX) by 10,450 shares to 16,960 shares, valued at $818,000 in 2017Q4, according to the filing. It also increased its holding in Carnival Corp. (NYSE:CCL) by 6,400 shares in the quarter, for a total of 30,950 shares, and has risen its stake in Kansas City So. (NYSE:KSU).

Analysts await Dycom Industries, Inc. (NYSE:DY) to report earnings on May, 23. They expect $0.69 earnings per share, down 46.92% or $0.61 from last year’s $1.3 per share. DY’s profit will be $21.52 million for 37.89 P/E if the $0.69 EPS becomes a reality. After $0.12 actual earnings per share reported by Dycom Industries, Inc. for the previous quarter, Wall Street now forecasts 475.00% EPS growth.

Among 10 analysts covering Dycom (NYSE:DY), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Dycom had 36 analyst reports since August 27, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, June 30 report. On Friday, November 17 the stock rating was maintained by FBR Capital with “Buy”. Stifel Nicolaus maintained Dycom Industries, Inc. (NYSE:DY) rating on Thursday, August 31. Stifel Nicolaus has “Buy” rating and $93.0 target. KeyBanc Capital Markets maintained the stock with “Overweight” rating in Tuesday, November 21 report. The rating was upgraded by KeyBanc Capital Markets to “Overweight” on Wednesday, August 30. As per Wednesday, February 28, the company rating was maintained by FBR Capital. The company was upgraded on Friday, May 26 by ValuEngine. DA Davidson upgraded Dycom Industries, Inc. (NYSE:DY) rating on Tuesday, December 15. DA Davidson has “Buy” rating and $95 target. B. Riley & Co maintained the shares of DY in report on Thursday, March 1 with “Buy” rating. The firm earned “Overweight” rating on Friday, February 9 by KeyBanc Capital Markets.

Investors sentiment increased to 1.18 in Q4 2017. Its up 0.13, from 1.05 in 2017Q3. It increased, as 12 investors sold BIOS shares while 28 reduced holdings. 19 funds opened positions while 28 raised stakes. 104.07 million shares or 0.29% less from 104.38 million shares in 2017Q3 were reported. Proshare Ltd Limited Liability Company has 0% invested in BioScrip, Inc. (NASDAQ:BIOS). Menta Llc accumulated 0.02% or 32,962 shares. Stratos Wealth Prtn Ltd invested in 1,000 shares. San Francisco Sentry Investment Gp (Ca) has 0% invested in BioScrip, Inc. (NASDAQ:BIOS). Morgan Stanley has invested 0% in BioScrip, Inc. (NASDAQ:BIOS). Moreover, American Intl Gp Inc has 0% invested in BioScrip, Inc. (NASDAQ:BIOS) for 78,248 shares. Geode Management Ltd Liability Corporation invested in 1.11M shares. Marathon Capital Mgmt reported 0.07% of its portfolio in BioScrip, Inc. (NASDAQ:BIOS). Citadel Advsrs, Illinois-based fund reported 16,951 shares. 65,000 were reported by Perkins. Roanoke Asset Management, a New York-based fund reported 403,280 shares. Tiaa Cref Inv Mgmt Ltd Liability Company owns 274,674 shares or 0% of their US portfolio. 12,430 are held by Susquehanna Group Llp. Salzhauer Michael has 24,075 shares for 0.03% of their portfolio. Portolan Ltd Liability Corp owns 362,323 shares.

Dycom Industries, Inc. (NYSE:DY) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>